61000 Federal Register / Vol. 77, No. 194 / Friday, October 5, 2012 / Notices 

Request for Comments 

In accordance with the Paperwork 

Reduction Act, comments on AHRQ’s 

information collection are requested 

with regard to any of the following: (a) 

Whether the proposed collection of 

information is necessary for the proper 

performance of AHRQ health care 

research and health care information 

dissemination functions, including 

whether the information will have 

practical utility; (b) the accuracy of 

AHRQ’s estimate of burden (including 

hours and costs) of the proposed 

collection(s) of information; (c) ways to 

enhance the quality, utility, and clarity 

of the information to be collected; and 

(d) ways to minimize the burden of the 

collection of information upon the 

respondents, including the use of 

automated collection techniques or 

other forms of information technology. 

Comments submitted in response to 

this notice will be summarized and 

included in the Agency’s subsequent 

request for OMB approval of the 

proposed information collection. All 

comments will become a matter of 

public record. 

Dated: September 27, 2012. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 2012–24454 Filed 10–4–12; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Meeting of the National Advisory 

Council for Healthcare Research and 

Quality 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), HHS. 

ACTION: Notice of public meeting. 

SUMMARY: In accordance with section 

10(a) of the Federal Advisory Committee 

Act, 5 U.S.C. App. 2, this notice 

announces a meeting of the National 

Advisory Council for Healthcare 

Research and Quality. 

DATES: The meeting will be held on 

Friday, November 9, 2012, from 8:30 

a.m. to 3:30 p.m. 

ADDRESSES: The meeting will be held at 

the Eisenberg Conference Center, 

Agency for Healthcare Research and 

Quality, 540 Gaither Road, Rockville, 

Maryland 20850. 

FOR FURTHER INFORMATION CONTACT: 

Jaime Zimmerman, Coordinator of the 

Advisory Council, at the Agency for 

Healthcare Research and Quality, 540 

Gaither Road, Rockville, Maryland 

20850, (301) 427–1456. For press-related 

information, please contact Alison Hunt 

at (301) 427–1244. 

If sign language interpretation or other 

reasonable accommodation for a 

disability is needed, please contact the 

Food and Drug Administration (FDA) 

Office of Equal Employment 

Opportunity and Diversity Management 

on (301) 827–4840, no later than Friday, 

October 26, 2012. The agenda, roster, 

and minutes are available from Ms. 

Bonnie Campbell, Committee 

Management Officer, Agency for 

Healthcare Research and Quality, 540 

Gaither Road, Rockville, Maryland 

20850. Ms. Campbell’s phone number is 

(301) 427–1554. 

SUPPLEMENTARY INFORMATION: 

I. Purpose 

The National Advisory Council for 

Healthcare Research and Quality is 

authorized by Section 941 of the Public 

Health Service Act, 42 U.S.C. 299c. In 

accordance with its statutory mandate, 

the Council is to advise the Secretary of 

the Department of Health and Human 

Services and the Director, Agency for 

Healthcare Research and Quality 

(AHRQ), on matters related to AHRQ’s 

conduct of its mission including 

providing guidance on (A) priorities for 

health care research, (B) the field of 

health care research including training 

needs and information dissemination on 

health care quality and (C) the role of 

the Agency in light of private sector 

activity and opportunities for public 

private partnerships. 

The Council is composed of members 

of the public, appointed by the 

Secretary, and Federal ex-officio 

members specified in the authorizing 

legislation. 

II. Agenda 

On Friday, November 9, 2012, there 

will be a subcommittee meeting for the 

National Healthcare Quality and 

Disparities Report scheduled to begin at 

7:30 a.m. The Council meeting will 

convene at 8:30 a.m., with the call to 

order by the Council Chair and approval 

of previous Council summary notes. The 

meeting will begin with a report from 

the National Advisory Council 

Subcommittee on the Children’s Health 

Insurance Program Reauthorization Act. 

The AHRQ Director will then present 

her update on current research, 

programs, and initiatives. Following the 

morning session, the Council will hold 

an Executive Session between the hours 

of 12:00 p.m. and 1:30 p.m. to discuss 

strategic issues related to the Agency for 

Healthcare Research and Quality. This 

Executive Session will be closed to the 

public in accordance with 5 U.S.C. App. 

2, section 10(d) and 5 U.S.C. 

552b(c)(9)(B). This portion of the 

meeting is likely to disclose information 

the premature disclosure of which 

would be likely to significantly frustrate 

implementation of a proposed agency 

action to the public. The final agenda 

will be available on the AHRQ Web site 

at www.AHRQ.gov no later than Friday, 

November 2, 2012. 

Dated: September 27, 2012. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 2012–24455 Filed 10–4–12; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Committee to the Director 

(ACD), Centers for Disease Control and 

Prevention—Health Disparities 

Subcommittee (HDS) 

In accordance with section 10(a) (2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting of the 

aforementioned subcommittee: 

Time and Date: 10 a.m.–12:15 p.m. 

EDT, October 24, 2012. 

Place: Teleconference. 

Status: Open to the public, limited 

only by the availability of telephone 

ports. The public is welcome to 

participate during the public comment 

period. A public comment period is 

tentatively scheduled for 12 p.m. to 

12:15 p.m. To participate in the 

teleconference, please dial (866) 561– 

5277 and enter code 2238494. 

Purpose: The Subcommittee will 

provide advice to the CDC Director 

through the ACD on strategic and other 

health disparities and health equity 

issues and provide guidance on 

opportunities for CDC. 

Matters to be discussed: Agenda items 

will include the following: Office of 

Minority Health and Health Equity 

updates; discussion of draft 

recommendations from April 2012 

meeting with the IOM Health Disparities 

Roundtable; discussion of Critical issues 

and Recommendations (Strategies to 

Strengthen CDC Response to Social 

Determinants of Health and Inequities); 

discussion regarding organizing the 

workflow of the HDS going forward; and 

HDS membership after June 2013. 

The agenda is subject to change as 

priorities dictate. 


pmangrum on DSK3VPTVN1PROD with NOTICES